Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Franklin, NJ
Chris Franklin, Keasbey, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110065765 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 03-17-2011 |
Chris Franklin, Quincy, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100273845 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 10-28-2010 |
Chris Franklin, Rahway, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100152259 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure (Formula I), wherein R an angiotensin receptor antagonist active group, Y is Y | 06-17-2010 |
Christopher Franklin, Quincy, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100292192 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 11-18-2010 |
Christopher L. Franklin, Keasbey, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100004280 | Substituted imidazoles as bombesin receptor subtype-3 modulators - Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes. | 01-07-2010 |
| 20100022598 | Substituted inmidazoles as bombesin receptor subtype-3 modulators - Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes. | 01-28-2010 |
| 20100204236 | Substituted imidazoles as bombesin receptor subtype-3 modulators - Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes. | 08-12-2010 |
Kerry Franklin, Monmouth Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100095421 | Protective pad for use during athletic activities - A protective pad to be employed by a person engaged in athletic activity utilizes to protect the user's hands formed from a very thin rectangular piece of rubber having a thickness of approximately 0.032 inch. On the top side of the protective pad are located treads upraised from the top surface of the pad. The treads are evenly spaced and approximately ½ inch apart and have triangular cross sections. The bottom side of the protective, which is the side placed against the grip portion of the piece of athletic equipment, is generally flat and has a tacky surface. The user wraps the protective pad around the grip portion of the piece of athletic equipment with the bottom tacky side of the pad adjacent to the grip. | 04-22-2010 |